Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
Couturier O, Faivre-Chauvet A, Filippovich IV, Thédrez P, Saï-Maurel C, Bardiès M, Mishra AK, Gauvrit M, Blain G, Apostolidis C, Molinet R, Abbe JC, Bataille R, Wijdenes J, Chatal JF, Chérel M. Couturier O, et al. Among authors: molinet r. Clin Cancer Res. 1999 Oct;5(10 Suppl):3165s-3170s. Clin Cancer Res. 1999. PMID: 10541359
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Among authors: molinet r. Cancer Res. 1999 Jun 1;59(11):2635-43. Cancer Res. 1999. PMID: 10363986
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Among authors: molinet r. Clin Cancer Res. 1999 Oct;5(10 Suppl):3031s-3043s. Clin Cancer Res. 1999. PMID: 10541340
Cytotoxicity of 213Bi- and 225Ac-immunoconjugates.
Kaspersen FM, Bos E, Doornmalen AV, Geerlings MW, Apostolidis C, Molinet R. Kaspersen FM, et al. Among authors: molinet r. Nucl Med Commun. 1995 Jun;16(6):468-76. doi: 10.1097/00006231-199506000-00009. Nucl Med Commun. 1995. PMID: 7675360
Cyclotron production of Ac-225 for targeted alpha therapy.
Apostolidis C, Molinet R, McGinley J, Abbas K, Möllenbeck J, Morgenstern A. Apostolidis C, et al. Among authors: molinet r. Appl Radiat Isot. 2005 Mar;62(3):383-7. doi: 10.1016/j.apradiso.2004.06.013. Appl Radiat Isot. 2005. PMID: 15607913
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
Nikula TK, McDevitt MR, Finn RD, Wu C, Kozak RW, Garmestani K, Brechbiel MW, Curcio MJ, Pippin CG, Tiffany-Jones L, Geerlings MW Sr, Apostolidis C, Molinet R, Geerlings MW Jr, Gansow OA, Scheinberg DA. Nikula TK, et al. Among authors: molinet r. J Nucl Med. 1999 Jan;40(1):166-76. J Nucl Med. 1999. PMID: 9935073 Free article.
In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
Vandenbulcke K, De Vos F, Offner F, Philippé J, Apostolidis C, Molinet R, Nikula TK, Bacher K, de Gelder V, Vral A, Lahorte C, Thierens H, Dierckx RA, Slegers G. Vandenbulcke K, et al. Among authors: molinet r. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1357-64. doi: 10.1007/s00259-003-1228-8. Epub 2003 Jul 3. Eur J Nucl Med Mol Imaging. 2003. PMID: 12845484
Targeted alpha particle immunotherapy for myeloid leukemia.
Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, Ballangrud AM, Hamacher KA, Ma D, Humm JL, Brechbiel MW, Molinet R, Scheinberg DA. Jurcic JG, et al. Among authors: molinet r. Blood. 2002 Aug 15;100(4):1233-9. Blood. 2002. PMID: 12149203 Free article. Clinical Trial.
Peer review and quality assurance.
Molinet RK, Halfpenny CF. Molinet RK, et al. J Fla Med Assoc. 1989 Apr;76(4):410. J Fla Med Assoc. 1989. PMID: 2794910 No abstract available.